Objective To research the effects of calcitonin gene-related peptide (CGRP) on the proliferation and osteogenic differentiation of bone mesenchymal stem cells (BMSCs) of osteoporotic rats in vitro. Methods Three-month-old SD rats were used, taking bilateral ovariectomy through the abdomen. Micro-computed tomography (Micro-CT) analysis was used to determine the success of modeling at 6 months after surgery. BMSCs were isolated from osteoporotic rats by blood adherence method. The biological characteristics of BMSCs were examined by flow cytometry. Different concentrations of CGRP (10-7-10-10 mol/L) were added to the culture medium of third generation BMSCs for examination of proliferation according CCK-8 method, alkaline phosphatase (ALP) activity and alizarin red staining were used to evaluate the ability of cells differentiation and mineralization. And reverse transcription polymerase chain reaction (RT-PCR) was used to detect the expression of ALP, Collagen I, BMP-2, Osteonectin and RunX2 gene. Western blotting was used to detect the expression of RunX2 and Osteonectin protein. Results The bone marrow stromal cells of osteoporotic rats were isolated successfully. The optical density (A) values of CCK-8 method increased in a dose-dependent manner, at 7 days, the control group of A value was 0.580 4±0.015 0, the CGRP group 10-7 mol/L was to 0.804 1±0.029 9(P=0.000), 10-8 mol/L to 0.788 6±0.028 0(P=0.000), 10-9 mol/L to 0.743 6±0.028 8 (P=0.001) and 10-10 mol/L to 0.693 3±0.029 2(P=0.004), difference was significant; The ALP activity was positive, at 14 days, the control group of A value was 4.633±0.423, the CGRP group 10-7 mol/L was to 44.047±2.446 (P=0.000), 10-8 mol/L to 42.030±2.626 (P=0.000), 10-9 mol/L to 39.333±0.527 (P=0.000), 10-10 mol/L to 24.647±1.135 (P=0.000) [unit: 10-3 μmol/(min·mg)}, difference was significant (P<0.05); The formation of calcium nodules were proved by alizarin red staining; The target genes expression were all increased, at 7 days, control group of ALP was to 0.999 5±0.205 0, 10-7 mol/L to 2.578 4±0.210 1(P=0.001), 10-10 mol/L to 2.351 2±0.201 2(P=0.001); The control group of BMP-2 was to 0.979 5±0.200 1, 10-7 mol/L to 3.427 9±0.255 2(P=0.000), 10-10 mol/L to 2.914 9±0.202 3(P=0.000); The control group of COLL-I was to 1.029 5±0.202 2, 10-7 mol/L to 2.518 7±0.240 0(P=0.001), 10-10 mol/L to 2.219 8±0.250 3; The control group of RunX2 was to 0.993 2±0.213 2, 10-7 mol/L to 2.498 9±0.262 0(P=0.002), 10-10 mol/L to 2.219 8±0.250 3(P=0.003); The control group of osteonectin was to 1.019 5±0.200 1, 10-7 mol/L to 1.972 8±0.212 3(P=0.005), 10-10 mol/L to 1.864 2±0.250 1 (P=0.010), difference was significant. The proteins expression of RunX2 and osteonectin were all increased. Conclusion Appropriate concentration (10-7 -10-10 mol/L) of CGRP can directly stimulate the proliferation, differentiation and mineralization of the BMSCs of osteoporotic rats in vitro, and CGRP may play an important role in the treatment of osteoporotic bone fracture repair. Key words: Calcitonin gene-related peptide; Osteoporosis; Bone mesenchymal stem cells; Osteogenic differentiation
Read full abstract